LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-18
Case ID: NM_006005.3_c.2452C_T_20261118_000242
Framework: ACMG/AMP 2015
Variant classification summary

NM_006005.3:c.2452C>T

WFS1  · NP_005996.2:p.(Arg818Cys)  · NM_006005.3
GRCh37: chr4:6303974 C>T  ·  GRCh38: chr4:6302247 C>T
Gene: WFS1 Transcript: NM_006005.3
Final call
VUS
PP3 supporting
All criteria require review: For research and educational purposes only.
Gene
WFS1
Transcript
NM_006005.3
Protein
NP_005996.2:p.(Arg818Cys)
gnomAD AF
0.005068333723764286 (v4.1)
ClinVar
Likely benign
OncoKB
Interpretation summary
Generated evidence synthesis
1
VUS: PP3 supporting was met because missense REVEL 0.758 exceeds the generic supporting threshold.
2
VUS: no pathogenic or benign rule was satisfied by the applied criteria.
Final determination: Under generic ACMG/AMP 2015 fallback rules, one supporting criterion alone satisfies no pathogenic, likely pathogenic, likely benign, or benign combination, so the call is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not met Not met: p.Arg818Cys is reported in one patient, but no previously established pathogenic same-amino-acid change is documented.
PMID:26025012 PMID:25741868
PS2 Not assessed Not assessed: no parental genotypes, maternity/paternity confirmation, or family-history data are reported for c.2452C>T (p.Arg818Cys).
PS3 Not assessed Not assessed: no variant-specific validated functional assay, assay control, or reproducible laboratory result is reported for WFS1 p.Arg818Cys.
PS4 Not met Not met: R818C was absent from 152 second-stage patients but present in one control, showing no affected-case enrichment and failing the PS4 OR >5.0 requirement.
PMID:12605098
PM1 Not met Not met: residue 818 has no documented critical-domain evidence or statistically significant hotspot, with Cancer Hotspots returning no result.
hotspots cosmic PMID:25741868
PM2 Not met Not met: gnomAD v4.1 total AF is 0.00506833, far above the generic PM2 supporting threshold of <=0.0001.
gnomad_v2 gnomad_v4 PMID:25741868
PM3 Not assessed Not assessed: the variant was reported with p.Gly780Ala, but no parental testing or other evidence establishes trans phase or pathogenicity of the partner.
PMID:26025012
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: no different missense variant at residue 818 has been determined pathogenic in the reviewed evidence.
pm5_candidates PMID:25741868
PM6 Not assessed Not assessed: the variant is reported in one participant, but no parental testing or other de novo evidence is provided.
PP1 Not assessed Not assessed: zero affected-relative meioses or variant-specific co-segregation results are reported for c.2452C>T (p.Arg818Cys).
PP2 Not assessed Not assessed: WFS1 has 156/309 reported missense variants, but the required low benign-missense rate is not established.
PMID:28432734 PMID:25741868
PP3 Met Met at supporting strength: missense REVEL 0.758 meets the generic PP3 supporting threshold of >=0.644.
revel
PP4 Not assessed Not assessed: the exact-variant report gives no specific patient phenotype or family history demonstrating a single-etiology WFS1 disorder.
PMID:26025012
PP5 Not met Not met: ClinVar has zero expert-panel submissions for exact R818C, and the available laboratory classifications are not pathogenic or likely pathogenic expert-panel evidence.
clinvar
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.00866652, below the generic BA1 threshold of 0.05 despite the higher Ashkenazi Jewish point estimate.
gnomad_v2 gnomad_v4 PMID:25741868
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.00866652, below the generic BS1 threshold of 0.01; the Ashkenazi Jewish point estimate is not the permitted metric.
gnomad_v2 gnomad_v4 PMID:28518168 PMID:25741868
BS2 Not assessed Not assessed: gnomAD reports 35 homozygotes, but no individual age or phenotype data confirm healthy adults as required for BS2 in recessive Wolfram syndrome.
gnomad_v2 gnomad_v4 PMID:12605098 PMID:11317350
BS3 Not assessed Not assessed: no variant-specific validated assay demonstrates preserved WFS1 protein function or splicing for p.Arg818Cys.
BS4 Not assessed Not assessed: no affected family members with documented variant status are available to demonstrate lack of segregation.
BP1 Not met Not met: reported WFS1 variants include 156/309 missense versus 111/309 frameshift or nonsense variants, not primarily truncating disease variation.
PMID:28432734 PMID:25741868
BP2 Not assessed Not assessed: a second variant was reported, but its cis/trans phase and pathogenicity are not established, so BP2's allelic requirement remains unresolved.
PMID:26025012
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: missense REVEL 0.758 exceeds the most permissive generic BP4 threshold of <=0.29.
revel
BP5 Not assessed Not assessed: R818C was reported with another WFS1 allele, but no separate molecular diagnosis or alternate disease basis was established.
PMID:26025012
BP6 Not met Not met: exact R818C has no ClinVar expert-panel classification, so ordinary benign or likely benign laboratory submissions cannot trigger BP6.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.